Randomized controlled trial of the effect of n–3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933 · see citing works

Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.

Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248 · see citing works

n-3 fatty acids and serum lipoproteins: human studies

Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243 · see citing works

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme

(2001) · European Heart Journal · doi:10.1053/euhj.2001.2610 · Cited by 893 · see citing works

Suppression by diets rich in fish oil of very low density lipoprotein production in man.

Nestel, P. J., CONNOR, W. E., Reardon, M., Connor, S. L., Wong, S., & Boston, R. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111422 · Cited by 616 · see citing works

Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men

Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., O’Neal, D. N., Best, J. D., & Beilin, L. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1085 · Cited by 588 · see citing works

Blood Volume

Gregersen, M. I., & Rawson, R. A. (1959) · Physiological Reviews · doi:10.1152/physrev.1959.39.2.307 · Cited by 285 · see citing works

Lipoprotein lipase in diabetes

Taskinen, M. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030208 · Cited by 273 · see citing works

Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans.

Illingworth, D. R., Harris, W. S., & CONNOR, W. E. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.3.270 · Cited by 255 · see citing works

Acute Effects of Insulin in the Control of VLDL Production in Humans: Implications for the insulin-resistant state

Lewis, G. F., & Steiner, G. A. (1996) · Diabetes Care · doi:10.2337/diacare.19.4.390 · Cited by 226 · see citing works

Omega-3 polyunsaturated fatty acid regulation of gene expression

Price, P. T., Nelson, C. M., & Clarke, S. D. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200002000-00002 · Cited by 222 · see citing works

Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B.

Egusa, G., Brady, D., Grundy, S. M., & Howard, B. V. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37908-6 · Cited by 213 · see citing works

Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity

Riches, F. M., Watts, G. F., Naoumova, R. P., Kelly, J., Croft, K. D., & Thompson, G. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800602 · Cited by 126 · see citing works

In Vivo Stimulation of Low-Density Lipoprotein Degradation by Insulin

Mazzone, T., Foster, D., & Chait, A. (1984) · Diabetes · doi:10.2337/diab.33.4.333 · Cited by 124 · see citing works

Metabolism of Very Low Density Lipoproteins in Hyperlipidaemia: Studies of Apolipoprotein B Kinetics in Man

Sigurdsson, G. T., Nicoll, A. D., & Lewis, B. (1976) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1976.tb00508.x · Cited by 120 · see citing works

Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity

Chan, D. C., Watts, G. F., Barrett, P. H., Mamo, J. C., & Redgrave, T. G. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.278 · Cited by 117 · see citing works

Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?

Mamo, J. C. L., Watts, G. F., Barrett, P. H. R., Smith, D., James, A. P., & Pal, S. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.3.e626 · Cited by 112 · see citing works

Task force 8. Organization of preventive cardiology service

Pearson, T. A., McBride, P. E., Miller, N. H., & Smith, S. C. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)87736-9 · Cited by 110 · see citing works

Reduction in Visceral Adipose Tissue Is Associated with Improvement in Apolipoprotein B-100 Metabolism in Obese Men1

Riches, F. M., Watts, G. F., Hua, J., Stewart, G. R., Naoumova, R. P., & Barrett, P. H. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5925 · Cited by 97 · see citing works

Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein.

Huff, M. W., & Telford, D. E. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.1.58 · Cited by 94 · see citing works

Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n−3 fatty acids

Westphal, S., Orth, M., Ambrosch, A., Osmundsen, K., & Luley, C. H. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.914 · Cited by 79 · see citing works

Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4‐dienoyl‐CoA reductase gene expression in rats

Willumsen, N., Vaagenes, H., Lie, Ø. H., Rustan, A. C., & Berge, R. K. (1996) · Lipids · doi:10.1007/bf02523828 · Cited by 74 · see citing works

Preliminary model for human lipoprotein metabolism in hyperlipoproteinemia.

Phair, R. D., Hammond, M. G., Bowden, J. A., Fried, M., Fisher, W. R., & Berman, M. M. (1975) · PubMed · Cited by 69 · see citing works

ApoB-100 Secretion by HepG2 Cells Is Regulated by the Rate of Triglyceride Biosynthesis but Not by Intracellular Lipid Pools

Benoist, F., & Grand‐Perret, T. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.10.1229 · Cited by 69 · see citing works

Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins

Lu, G., Windsor, S. L., & Harris, W. S. (1999) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(98)00094-1 · Cited by 62 · see citing works

Effects of fish oil supplementation on apolipoprotein B100 production and lipoprotein metabolism in normolipidaemic males

Bordin, P., Bodamer, O. A., Venkatesan, S., Gray, R., Pa, B., & Halliday, D. (1998) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600522 · Cited by 58 · see citing works

Postprandial lipoprotein lipase, insulin and gastric inhibitory polypeptide responses to test meals of different fatty acid composition: comparison of saturated, n-6 and n-3 polyunsaturated fatty acids.

Zampelas, A., Murphy, M. C., Morgan, L., & Williams, C. M. (1994) · PubMed · Cited by 52 · see citing works

Analysis of native and oxidized low-density lipoprotein oxysterols using gas chromatography—mass spectrometry with selective ion monitoring

Mori, T. A., Croft, K. D., Puddey, I. B., & Beilin, L. J. (1996) · Redox Report · doi:10.1080/13510002.1996.11747023 · Cited by 50 · see citing works

Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice

Martins, I. J., Hone, E., Chi, C., Seydel, U., Martins, R. N., & Redgrave, T. G. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32054-x · Cited by 44 · see citing works

Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity

Watts, G. F., Riches, F. M., Humphries, S. E., Talmud, P. J., & BOCKXMEER, F. M. V. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34487-4 · Cited by 44 · see citing works

Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet

Fisher, W. R., Zech, L. A., & Stacpoole, P. W. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33900-6 · Cited by 37 · see citing works

Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma.

Cummings, M. H., Watts, G. F., Lumb, P. J., & Slavin, B. M. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.2.176 · Cited by 29 · see citing works

Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test

Redgrave, T. G., Watts, G. F., Martins, I. J., Barrett, P. H. R., Mamo, J. C. L., Dimmitt, S. B., & Marais, A. D. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31632-1 · Cited by 29 · see citing works

Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review

Schwab, U., Lauritzen, L., Tholstrup, T., Halldorsson, T. I., Risérus, U., Uusitupa, M. I. J., & Becker, W. (2014) · Food & Nutrition Research · doi:10.3402/fnr.v58.25145 · Cited by 386 · see citing works

Omega-3 fatty acids in obesity and metabolic syndrome: A mechanistic update

Albracht-Schulte, K., Kalupahana, N. S., Ramalingam, L., Wang, S., Rahman, S. M., Robert-McComb, J., & Moustaid-Moussa, N. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.012 · Cited by 355 · see citing works

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review

Nettleton, J. A., & Katz, R. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.11.029 · Cited by 339 · see citing works

Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease

Scorletti, E., & Byrne, C. D. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161230 · Cited by 326 · see citing works

Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis

Eslick, G. D., Howe, P. R. C., Smith, C., Priest, R., & Bensoussan, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.092 · Cited by 299 · see citing works

Fish oil — How does it reduce plasma triglycerides?

Shearer, G. C., Savinova, O. V., & Harris, W. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.011 · Cited by 285 · see citing works

The impact of long-chainn-3 polyunsaturated fatty acids on human health

Ruxton, C. H. S., Calder, P. C., Reed, S. C., & Simpson, M. J. A. (2005) · Nutrition Research Reviews · doi:10.1079/nrr200497 · Cited by 274 · see citing works

Causes and consequences of hypertriglyceridemia

Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239 · see citing works

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

Kastelein, J. J. P., Maki, K. C., Susekov, A., Ezhov, M., Nordestgaard, B. G., Machielse, B. N., Kling, D., & Davidson, M. H. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.10.003 · Cited by 233 · see citing works

Means of Delivering Recommended Levels of Long Chain n‐3 Polyunsaturated Fatty Acids in Human Diets

Garg, M. L., Wood, L. G., Singh, H., & Moughan, P. J. (2006) · Journal of Food Science · doi:10.1111/j.1750-3841.2006.00033.x · Cited by 207 · see citing works

Current Evidence Supporting the Link Between Dietary Fatty Acids and Cardiovascular Disease

Hammad, S. S., Pu, S., & Jones, P. J. H. (2015) · Lipids · doi:10.1007/s11745-015-4113-x · Cited by 201 · see citing works

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

Kelley, D. S., Siegel, D., Vemuri, M., & Mackey, B. E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.324 · Cited by 179 · see citing works

Polyunsaturated fatty acids and their effects on cardiovascular disease.

Ander, B. P., Dupasquier, C. M. C., Prociuk, M. A., & Pierce, G. N. (2003) · PubMed Central · Cited by 180 · see citing works

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review

Oscarsson, J., & Hurt-Camejo, E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0541-3 · Cited by 158 · see citing works

DHA Supplementation Decreases Serum C-Reactive Protein and Other Markers of Inflammation in Hypertriglyceridemic Men

Kelley, D. S., Siegel, D., Fedor, D. M., Adkins, Y. C., & Mackey, B. E. (2009) · Journal of Nutrition · doi:10.3945/jn.108.100354 · Cited by 139 · see citing works

n-3 Fatty Acids in the Treatment of Diabetic Patients

Caterina, R. D., Madonna, R., Bertolotto, A., & Schmidt, E. B. (2007) · Diabetes Care · doi:10.2337/dc06-1332 · Cited by 135 · see citing works

Role of Prescription Omega‐3 Fatty Acids in the Treatment of Hypertriglyceridemia

McKenney, J. M., & Sica, D. A. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.5.715 · Cited by 131 · see citing works

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease

Perla, F. M., Prelati, M., Lavorato, M., Visicchio, D., & Anania, C. (2017) · Children · doi:10.3390/children4060046 · Cited by 129 · see citing works

The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review

Pizzini, A., Lunger, L., Demetz, E., Hilbe, R., Weiß, G., Ebenbichler, C. F., & Tancevski, I. (2017) · Nutrients · doi:10.3390/nu9101099 · Cited by 117 · see citing works

The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease

Shapiro, H., Tehilla, M., Attal-Singer, J., Bruck, R., Luzzatti, R., & Singer, P. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.06.001 · Cited by 112 · see citing works

Dyslipidemia in Visceral Obesity

Chan, D., Barrett, H., & Watts, G. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404040-00004 · Cited by 69 · see citing works

Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial

Scorletti, E., West, A. L., Bhatia, L. S., Hoile, S. P., McCormick, K. G., Burdge, G. C., Lillycrop, K. A., Clough, G. F., Calder, P. C., & Byrne, C. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.036 · Cited by 108 · see citing works

A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)

Maki, K. C., Orloff, D. G., Nicholls, S. J., Dunbar, R. L., Roth, E. M., Curcio, D., Johnson, J., Kling, D., & Davidson, M. H. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.07.420 · Cited by 104 · see citing works

Role of ω3 Longchain Polyunsaturated Fatty Acids in Reducing Cardio- Metabolic Risk Factors

Abeywardena, M. Y., & Patten, G. S. (2011) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153011796429817 · Cited by 104 · see citing works

Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease

Shibabaw, T. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03965-7 · Cited by 108 · see citing works

Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: A meta-analysis of randomized clinical trials

Zhang, Y. Y., Liu, W., Zhao, T. Y., & Tian, H. M. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0755-5 · Cited by 101 · see citing works

Effects of omega-3 fatty acids on cardiovascular disease.

Wang, C., Chung, M. C., Lichtenstein, A. H., Balk, E. M., Kupelnick, B., DeVine, D., Lawrence, A., & Lau, J. (2004) · PubMed Central · Cited by 96 · see citing works

Factorial study of the effect of n–3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity

Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.37 · Cited by 96 · see citing works

Thematic review series: Patient-Oriented Research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns

Lichtenstein, A. H. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600019-jlr200 · Cited by 95 · see citing works

Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia

McKenney, J. M., & Sica, D. A. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060164 · Cited by 94 · see citing works

An Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids

Yanai, H., Masui, Y., Katsuyama, H., Adachi, H., Kawaguchi, A., Hakoshima, M., Waragai, Y., Harigae, T., & Sako, A. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3362w · Cited by 93 · see citing works

Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study

Offman, E., Marenco, T., Ferber, S., Johnson, J., Kling, D., Curcio, D., & Davidson, M. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s50464 · Cited by 92 · see citing works

The triglyceride–high-density lipoprotein axis: An important target of therapy?

Szapary, P. O., & Rader, D. J. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.037 · Cited by 87 · see citing works

Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence

Maki, K. C., Bays, H. E., & Dicklin, M. R. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.04.003 · Cited by 83 · see citing works

Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia

Maki, K. C., Bays, H. E., Dicklin, M. R., Johnson, S. L., & Shabbout, M. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.09.001 · Cited by 81 · see citing works

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism

Green, C., Pramfalk, C., Charlton, C. A., Gunn, P. J., Cornfield, T., Pavlides, M., Karpe, F., & Hodson, L. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000871 · Cited by 85 · see citing works

Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles

Qi, K., Fan, C., Jin, J., Zhu, H., Jiao, H., Meng, Q., & Deckelbaum, R. J. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.02.001 · Cited by 85 · see citing works

Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil

Olano-Martin, E., Anil, E., Caslake, M. J., Packard, C. J., Bedford, D., Stewart, G., Peiris, D., Williams, C. M., & Minihane, A. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.024 · Cited by 83 · see citing works

Effects of Adding Prescription Omega-3 Acid Ethyl Esters to Simvastatin (20 mg/day) on Lipids and Lipoprotein Particles in Men and Women With Mixed Dyslipidemia

Maki, K. C., McKenney, J. M., Reeves, M. S., Lubin, B. C., & Dicklin, M. R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.03.078 · Cited by 81 · see citing works

Inclusion of fish or fish oil in weight-loss diets for young adults: Effects on blood lipids

Gunnarsdottir, I., Tomasson, H., Kiely, M., Martinéz, J. A., Bandarra, N. M., Morais, M. G., & Thorsdottir, I. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.64 · Cited by 79 · see citing works

Regulation of chylomicron production in humans

Xiao, C., & Lewis, G. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.019 · Cited by 77 · see citing works

Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial

Asztalos, I. B., Gleason, J. A., Sever, S., Gedik, R., Asztalos, B. F., Horvath, K. V., Dansinger, M. L., Lamon‐Fava, S., & Schaefer, E. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.010 · Cited by 74 · see citing works

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

Davidson, M. H., Maki, K. C., Bays, H., Carter, R., & Ballantyne, C. M. (2009) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2009.08.001 · Cited by 71 · see citing works

Associations of low density lipoprotein particle composition with atherogenicity

Lada, A. T., & Rudel, L. L. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200402000-00005 · Cited by 71 · see citing works

Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol

Maki, K. C., Elswyk, M. E. V., McCarthy, D., Hess, S. P., Veith, P. E., Bell, M., Subbaiah, P. V., & Davidson, M. H. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719465 · Cited by 67 · see citing works

Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?

Darwesh, A. M., Bassiouni, W., Sosnowski, D. K., & Seubert, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107703 · Cited by 66 · see citing works

Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effects vs . clinical outcomes

Thota, R. N., Ferguson, J. J. A., Abbott, K. A., Dias, C. B., & Garg, M. L. (2018) · Food & Function · doi:10.1039/c8fo00348c · Cited by 60 · see citing works

Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Chang, J. P., Tseng, P., Zeng, B., Chang, C., Su, H., Chou, P., & Su, K. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.003 · Cited by 59 · see citing works

Conjugated linoleic acid, unlike other unsaturated fatty acids, strongly induces glutathione synthesis without any lipoperoxidation

Arab, K., Rossary, A., Soulère, L., & Steghens, J. (2006) · British Journal Of Nutrition · doi:10.1017/bjn20061910 · Cited by 58 · see citing works

Nonalcoholic fatty liver disease and lipids

Wierzbicki, A. S., & Oben, J. A. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283541cfc · Cited by 58 · see citing works

Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment

Galimberti, F., Casula, M., & Olmastroni, E. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106873 · Cited by 63 · see citing works

Effects of N-3 Fatty Acids on Hepatic Triglyceride Content in Humans

Vega, G. L., Chandalia, M., Szczepaniak, L. S., & Grundy, S. M. (2008) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318177024d · Cited by 56 · see citing works

Intake of Fish Oil, Oleic Acid, Folic Acid, and Vitamins B-6 and E for 1 Year Decreases Plasma C-Reactive Protein and Reduces Coronary Heart Disease Risk Factors in Male Patients in a Cardiac Rehabilitation Program

Carrero, J. J., Fonollá, J., Marti, J. L., Jiménez, J., Bozá, J., & López‐Huertas, E. (2007) · Journal of Nutrition · doi:10.1093/jn/137.2.384 · Cited by 56 · see citing works

The role of marine n-3 fatty acids in improving cardiovascular health: a review

Nicholson, T., Khademi, H., & Moghadasian, M. H. (2013) · Food & Function · doi:10.1039/c2fo30235g · Cited by 56 · see citing works

Camelina Sativa Oil, but not Fatty Fish or Lean Fish, Improves Serum Lipid Profile in Subjects with Impaired Glucose Metabolism—A Randomized Controlled Trial

Schwab, U., Lankinen, M. A., de Mello, V. D., Manninen, S. M., Kurl, S., Pulkki, K. J., Laaksonen, D. E., & Erkkilä, A. T. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700503 · Cited by 53 · see citing works

Docosahexaenoic Acid Supplementation Decreases Remnant-Like Particle-Cholesterol and Increases the (n-3) Index in Hypertriglyceridemic Men

Kelley, D. S., Siegel, D., Vemuri, M., Chung, G. H., & Mackey, B. E. (2008) · Journal of Nutrition · doi:10.1093/jn/138.1.30 · Cited by 52 · see citing works

Prudent diet and preventive nutrition from pediatrics to geriatrics: current knowledge and practical recommendations.

Enas, E. A., Senthilkumar, A., Chennikkara, H., & Bjurlin, M. A. (2003) · PubMed · Cited by 46 · see citing works

Supplementation with EPA and DHA omega-3 fatty acids improves peripheral immune cell mitochondrial dysfunction and inflammation in subjects with obesity

Borja-Magno, A. I., Furuzawa‐Carballeda, J., Guevara‐Cruz, M., Arias, C., Granados, J., Bourges, H., Tovar, A. R., Sears, B., Noriega, L. G., & Gómez, F. E. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109415 · Cited by 45 · see citing works

Functional foods and nutraceuticals in the management of obesity

Kasbia, G. S. (2005) · Nutrition & Food Science · doi:10.1108/00346650510625557 · Cited by 45 · see citing works

Regulation of Cholesterol Metabolism by Phytochemicals Derived from Algae and Edible Mushrooms in Non-Alcoholic Fatty Liver Disease

Eilam, Y., Pintel, N., Khattib, H., Shagug, N., Taha, R., & Avni, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213667 · Cited by 48 · see citing works

Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods

Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · Clinical Science · doi:10.1042/cs20040109 · Cited by 44 · see citing works

Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects

Ooi, E. M. M., Lichtenstein, A. H., Millar, J. S., Diffenderfer, M. R., Lamon‐Fava, S., Rasmussen, H., Welty, F. K., Barrett, P. H. R., & Schaefer, E. J. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p024315 · Cited by 43 · see citing works

Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males

MARKOVIC, O. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.02.002 · Cited by 41 · see citing works

The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia

Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.001 · Cited by 40 · see citing works

Optimal Management of Combined Dyslipidemia: What Have We Behind Statins Monotherapy?

Tenenbaum, A., Fisman, E. Z., Motro, M., & Adler, Y. (2008) · Advances in cardiology · doi:10.1159/000115192 · Cited by 38 · see citing works

Treatment of Hypertriglyceridemia With Omega‐3 Fatty Acids: A Systematic Review

Lewis, A., Lookinland, S., Beckstrand, R. L., & Tiedeman, M. E. (2004) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2004.tb00388.x · Cited by 38 · see citing works

Fish oil in the treatment of dyslipidemia

Goldberg, R. B., & Sabharwal, A. K. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f76728 · Cited by 37 · see citing works

The Effect of a 12-Week Course of Omega-3 Polyunsaturated Fatty Acids on Lipid Parameters in Hypertriglyceridemic Adult HIV-infected Patients Undergoing HAART: A Randomized, Placebo-Controlled Pilot Trial

Peters, B. S., Wierzbicki, A. S., Moyle, G. J., Nair, D. R., & Brockmeyer, N. H. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.001 · Cited by 35 · see citing works

Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects

Perona, J. S., Covas, M.-I., Fitó, M., Cabello-Moruno, R., Arós, F., Corella, D., Ros, E., Garcia, M., Estruch, R., Martínez‐González, M. Á., et al. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.07.005 · Cited by 35 · see citing works

Effect of omega-3 fatty acid plus vitamin E Co-Supplementation on lipid profile: A systematic review and meta-analysis

Sepidarkish, M., Morvaridzadeh, M., Akbari‐Fakhrabadi, M., Almasi‐Hashiani, A., Rezaeinejad, M., & Heshmati, J. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.03.018 · Cited by 34 · see citing works

N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications

Salek, M., Clark, C. C. T., Taghizadeh, M., & Jafarnejad, S. (2019) · EXCLI journal · doi:10.17179/excli2019-1534 · Cited by 40 · see citing works

ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia

Chan, D. C., Pang, J., Barrett, P. H. R., SULLIVAN, D. R., Burnett, J. R., BOCKXMEER, F. M. V., & Watts, G. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2217 · Cited by 34 · see citing works

Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo

Watts, G. F., Ooi, E. M. M., & Chan, D. C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.04.005 · Cited by 33 · see citing works

Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids

Brunton, S., & Collins, N. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x188017 · Cited by 33 · see citing works

Novel developments in omega-3 fatty acid-based strategies

Davidson, M. H., Kling, D. F., & Maki, K. C. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834bd642 · Cited by 32 · see citing works

Attenuated secretion of very low density lipoproteins from McA-RH7777 cells treated with eicosapentaenoic acid is associated with impaired utilization of triacylglycerol synthesized via phospholipid remodeling

Tran, K. T., Sun, F., Cui, Z., Thorne‐Tjomsland, G., Germain, C. S., Lapierre, L. R., McLeod, R. S., Jamieson, J. C., & Yao, Z. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.018 · Cited by 32 · see citing works

Effect of <i>n</i>-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects

Ouguerram, K., Maugeais, C., Gardette, J., Magot, T., & Krempf, M. (2006) · British Journal of Nutrition · doi:10.1079/bjn20061806 · Cited by 31 · see citing works

Omega-3 fatty acids and inflammation: A perspective on the challenges of evaluating efficacy in clinical research

Skulas‐Ray, A. C. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.02.001 · Cited by 31 · see citing works

Effects of Prescription Omega-3-Acid Ethyl Esters on Fasting Lipid Profile in Subjects With Primary Hypercholesterolemia

Maki, K. C., Lawless, A. L., Kelley, K., Dicklin, M. R., Kaden, V. N., Schild, A. L., Rains, T. M., & Marshall, J. W. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318210fca5 · Cited by 31 · see citing works

Lipid-modifying effects of krill oil vs fish oil: a network meta-analysis

Kim, M. G., Yang, I., Lee, H. S., Lee, J., & Kim, K. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz102 · Cited by 31 · see citing works

Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia

Skulas-Ray, A. C., Alaupovic, P., Kris-Etherton, P. M., & West, S. G. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.12.001 · Cited by 30 · see citing works

Effect of ω-3 Fatty Acid Ethyl Esters on Apolipoprotein B-48 Kinetics in Obese Subjects on a Weight-Loss Diet: A New Tracer Kinetic Study in the Postprandial State

Wong, A. T. Y., Chan, D. C., Barrett, P. H. R., Adams, L. A., & Watts, G. F. (2014) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2013-4037 · Cited by 30 · see citing works

SEASONAL VARIATIONS OF TOTAL LIPID AND FATTY ACID CONTENTS IN THE MUSCLE OF TWO AUSTRALIAN FARMED ABALONE SPECIES

SU, X., Antonas, K., Li, D., & Nichols, P. D. (2006) · Journal of Food Lipids · doi:10.1111/j.1745-4522.2006.00063.x · Cited by 30 · see citing works

The chronic effects of fish oil with exercise on postprandial lipaemia and chylomicron homeostasis in insulin resistant viscerally obese men

Clark, K., James, A. P., & Mamo, J. C. L. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-9 · Cited by 30 · see citing works

High-Dose DHA Has More Profound Effects on LDL-Related Features Than High-Dose EPA: The ComparED Study

Allaire, J., Vors, C., Tremblay, A. J., Marin, J., Charest, A., Tchernof, A., Couture, P., & Lamarche, B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02745 · Cited by 29 · see citing works

Effects of dietary fish oil on thyroid hormone signaling in the liver

Souza, L. L., Nunes, M. O., de Paula, G. S. M., Cordeiro, A., Penha-Pinto, V., Neto, J. F. N., Oliveira, K. J., do Carmo, M. D. G. T., & Pazos-Moura, C. C. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.07.008 · Cited by 29 · see citing works

Distinct Influence of Omega-3 Fatty Acids on the Plasma Metabolome of Healthy Older Adults

Xyda, S., Vučković, I., Petterson, X.-M. T., Dasari, S., Lalia, A. Z., Parvizi, M., Macura, S. I., & Lanza, I. R. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz141 · Cited by 28 · see citing works

Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia

Choi, H. D., & Chae, S. M. (2018) · Medicine · doi:10.1097/md.0000000000013593 · Cited by 28 · see citing works

Herring (Clupea harengus) supplemented diet influences risk factors for CVD in overweight subjects

Lindqvist, H., Langkilde, A. M., Undeland, I., Rådendal, T., & Sandberg, A. S. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602630 · Cited by 27 · see citing works

Omega-3 Fatty Acids

Harris, W. S., & Jacobson, T. A. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50031-7 · Cited by 27 · see citing works

Characterization of Lecithin Isolated from Anchovy ( Engraulis japonica ) Residues Deoiled by Supercritical Carbon Dioxide and Organic Solvent Extraction

Lee, S., Asaduzzaman, A. K. M., & Chun, B. (2012) · Journal of Food Science · doi:10.1111/j.1750-3841.2012.02764.x · Cited by 25 · see citing works

Nutritional supplements and serum lipids: Does anything work?

McGowan, M. P., & Proulx, S. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0070-2 · Cited by 24 · see citing works

Baseline Lipoprotein Lipids and Low-Density Lipoprotein Cholesterol Response to Prescription Omega-3 Acid Ethyl Ester Added to Simvastatin Therapy

Maki, K. C., Dicklin, M. R., Davidson, M. H., Doyle, R. T., & Ballantyne, C. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.063 · Cited by 24 · see citing works

Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet

Wong, A. T. Y., Chan, D. C., Barrett, P. H. R., Adams, L. A., & Watts, G. F. (2013) · The Journal of Nutrition · doi:10.3945/jn.112.169359 · Cited by 23 · see citing works

Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients

Bays, H. E., Maki, K. C., McKenney, J. M., Snipes, R., Meadowcroft, A. M., Schroyer, R., Doyle, R. T., & Stein, E. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003645318 · Cited by 22 · see citing works

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3

Catapano, A. L., & Pirillo, A. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s67551 · Cited by 22 · see citing works

Unravelling lipoprotein metabolism with stable isotopes: tracing the flow

Ying, Q., Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154887 · Cited by 21 · see citing works

Modulation of the mRNA of the Nlrp3 inflammasome by Morin and PUFAs in an obesity model induced by a high-fat diet

López-Tenorio, I. I., Domínguez‐López, A., Miliar-García, Á., Escalona-Cardoso, G. N., Real-Sandoval, S. A., Alcalá, A. G., & Jaramillo‐Flores, M. E. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109706 · Cited by 20 · see citing works

Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men

Wong, A. T. Y., Chan, D. C., Ooi, E. M. M., Ng, T. W., Watts, G. F., & Barrett, P. H. R. (2013) · Clinical Science · doi:10.1042/cs20120587 · Cited by 20 · see citing works

Fish oil significantly alters fatty acid profiles in various lipid fractions but not atherogenesis in apo E-KO mice

Xu, Z., Riediger, N. D., Innis, S. M., & Moghadasian, M. H. (2007) · European Journal of Nutrition · doi:10.1007/s00394-006-0638-3 · Cited by 20 · see citing works

Effects of fish oil supplementation on apolipoprotein B100 production and lipoprotein metabolism in normolipidaemic males

Bordin, P., Bodamer, O. A., Venkatesan, S., Gray, R., Pa, B., & Halliday, D. (1998) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600522 · Cited by 58 · see citing works

Effects of atorvastatin and n−3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity

Chan, D. C., Nguyen, M. N., Watts, G. F., Ooi, E. M. M., & Barrett, P. H. R. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28422 · Cited by 29 · see citing works

Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia

Chan, D. C., Watts, G. F., Barrett, P. H. R., Beilin, L. J., Redgrave, T. G., & Mori, T. A. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2377 · Cited by 160 · see citing works

Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet

Fisher, W. R., Zech, L. A., & Stacpoole, P. W. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33900-6 · Cited by 37 · see citing works

Suppression by diets rich in fish oil of very low density lipoprotein production in man.

Nestel, P. J., CONNOR, W. E., Reardon, M., Connor, S. L., Wong, S., & Boston, R. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111422 · Cited by 616 · see citing works